APT contracts IP Infusion for 5G Cell Site Router deployment

20 Jul 2020

IP Infusion has announced that Taiwan’s Asia Pacific Telecom (APT) has selected it to deliver ‘a comprehensive disaggregated solution for the deployment of [the cellco’s] 5G mobile network’. In a press release the vendor said that its disaggregated cell site router (CSR) solution – which it will provide in partnership with UfiSpace and Foxconn Global Network Co. (FHnet) – will deliver routers that can support the increased 5G data volumes and yet be compact, efficient, and simple to maintain. Further, it claims that that CSR solution will also deliver significant CAPEX and OPEX savings through the use of white-box hardware and a network operating system (NOS) that includes advanced capabilities such as switching, routing and Multiprotocol Label Switching (MPLS).

Commenting, APT Senior Vice President JM Chien said: ‘IP Infusion, UfiSpace and FHnet are delivering the solution that will help APT to establish a fast, reliable 5G network for Taiwan’s consumers and business users … As we enter the new era of 5G, we will be able to accelerate network transformation, expand the depth and breadth of 5G applications, and realise more business opportunities in a more flexible manner. We will be leveraging the benefits of IP Infusion’s open software platform and white box hardware to gain cost savings and efficiencies in our network.’

Taiwan, Asia Pacific Telecom (APT), IP Infusion